Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJDS.L Regulatory News (JDS)

  • There is currently no data for JDS

Interim Management Statement

7 May 2014 12:33

RNS Number : 4757G
Mandarin Oriental International Ltd
07 May 2014
 

To: Business Editor For immediate release

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

7th May 2014 ‒ Mandarin Oriental International Limited has today issued its Interim Management Statement covering the period from 1st January to 6th May 2014.

 

The trading performance across the Group during the period was broadly stable. In Asia, the results of the Hong Kong and Singapore hotels remained steady, while Bangkok continued to be affected by challenging conditions. Europe benefited from further stabilization of the Paris hotel and improvement in Geneva, which more than offset softer demand in London. In The Americas, while the majority of hotels increased their average rates, the overall performance was impacted by lower demand in Washington when compared to the same period last year, which included the 2013 Presidential Inauguration.

 

In March, the Group entered into an agreement with a local development partner to expand its wholly-owned hotel in Munich. A mixed-use complex is to be constructed on an adjacent site that will include a hotel element in which the Group will have a freehold interest. The Group's total projected investment in the complex, which is due to open in 2021, is estimated at €124 million (US$170 million) in today's terms, and will include a refurbishment of the existing hotel's rooms.

 

During the period, a new management contract was announced for a 121-room luxury resort located on Bali's southern peninsula, scheduled to open in 2017. The Group has ceased management of two unbranded hotels; the Grand Lapa hotel in Macau in January and the Elbow Beach hotel in Bermuda in March.

 

Two new hotels are scheduled to open within the next six months, in Taipei, Taiwan and in Bodrum, Turkey.

 

The Group's financial position remains healthy, with net debt remaining in line with that reported at 31st December 2013.

 

On 8th April 2014 shareholders approved the transfer of the Company's share listing on the Main Market of the London Stock Exchange to the standard segment from the premium segment. The transfer is expected to become effective on 27th May 2014.

 

Mandarin Oriental Hotel Group is the award-winning owner and operator of some of the most luxurious hotels, resorts and residences. Having grown from a well-respected Asian hotel company into a global brand, the Group now operates, or has under development, 44 hotels representing close to 11,000 rooms in 25 countries, with 20 hotels in Asia, ten in The Americas and 14 in Europe, Middle East and North Africa. In addition, the Group operates or has under development, 13 Residences at Mandarin Oriental connected to its properties. Mandarin Oriental International Limited is incorporated in Bermuda and has its primary listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

Hamish Ross (852) 2895 9288

Sally de Souza (852) 2895 9167

 

GolinHarris

Kennes Young (852) 2501 7987

 

This and other Group announcements can be accessed through the internet at 'www.mandarinoriental.com'.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFDLFBZEFXBBL
Date   Source Headline
27th May 201110:57 amRNSShares Purchase
26th May 201111:38 amRNSShares Purchase
25th May 201111:48 amRNSShares Purchase
24th May 201112:38 pmRNSShares Purchase
18th May 201111:31 amRNSDirector/PDMR Shareholding
13th May 201110:13 amRNSAdditional Listing
12th May 20113:55 pmRNSAGM Statement
12th May 20113:48 pmRNSResult of AGM
12th May 20111:12 pmRNSDirectorate Change
12th May 201112:35 pmRNSInterim Management Statement
4th May 201110:51 amRNSDividend
3rd May 201110:56 amRNSAnnual Information Update
28th Apr 201110:58 amRNSJC&C Q1 Results
28th Apr 201110:36 amRNSAstra First Quarter Results
21st Apr 201111:58 amRNSDividend
7th Apr 201110:29 amRNSAnnual Financial Report
6th Apr 201112:38 pmRNSShares Purchase
1st Apr 201111:55 amRNSShares Purchase
30th Mar 201110:13 amRNSCirc re. Scrip Dividend Scheme
4th Mar 20119:05 amRNSFinal Results
25th Feb 20119:16 amRNSJC&C 2010 Full Year Financial Statements
24th Feb 20119:48 amRNSAstra 2010 Full Year Financial Statements
7th Feb 20119:17 amRNSNotice of 2010 Final Results
10th Nov 20109:18 amRNSInterim Management Statement
29th Oct 201010:12 amRNSTotal Voting Rights
28th Oct 201011:14 amRNSAstra 2010 Third Quarter Financial Statements
13th Oct 201010:13 amRNSDirector/PDMR Shareholding
7th Oct 201010:12 amRNSAdditional Listing
29th Sep 201010:09 amRNSDividend
27th Sep 201012:42 pmRNSDividend
7th Sep 201012:30 pmRNSDirector/PDMR Shareholding
1st Sep 201010:31 amRNSCirc re. Scrip Dividend Scheme
30th Jul 201010:29 amRNSJC&C 2010 Half Year Financial Statements
30th Jul 201010:29 amRNSHalf Yearly Report
29th Jul 201010:26 amRNSAstra 2010 Half Year Financial Statements
2nd Jul 201010:16 amRNSNotice of 2010 Half-Yearly Results
1st Jun 201010:57 amRNSTotal Voting Rights
24th May 20107:00 amRNSTransaction in Own Shares
12th May 201011:16 amRNSDirector/PDMR Shareholding
7th May 20109:14 amRNSAdditional Listing
6th May 20103:40 pmRNSAGM Statement
6th May 20103:37 pmRNSResult of AGM
6th May 201012:33 pmRNSInterim Management Statement
30th Apr 201010:30 amRNSTotal Voting Rights
29th Apr 201010:47 amRNSJC&C First Quarter 2010 Financial Statements
29th Apr 201010:45 amRNSAstra First Quarter 2010 Results
28th Apr 201010:46 amRNSDividend
26th Apr 201010:53 amRNSAnnual Information Update
26th Apr 201010:19 amRNSDividend
8th Apr 20107:00 amRNSResults of Tender Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.